Highlights Connect Biopharma Holdings Limited

Equities

CNTB

US2075231017

Delayed Nasdaq Other stock markets 03:20:14 2024-05-21 pm EDT			5-day change	1st Jan Change
1.74 ^USD	+4.19%		-10.77%	+47.46%

Apr. 17	Sector Update: Health Care Stocks Retreating Late Afternoon	MT
Apr. 17	Sector Update: Health Care	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Retreating Late Afternoon	Apr. 17	MT
Sector Update: Health Care	Apr. 17	MT
Connect Biopharma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
ADRs Advance, Eco Wave Power Global AB Climbs 213.4%	Apr. 08	DJ
ADRs Advance; Connect Biopharma Climbs 19%	Apr. 05	DJ
ADRs Close Lower; Moatable Inc. Declines 33.3%	Apr. 04	DJ
ADRs End Higher; Connect Biopharma Climbs 26%	Apr. 01	DJ
Connect Biopharma Holdings Limited Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-To-Severe Persistent Asthma	Dec. 12	CI
Simcere Pharmaceutical Group Limited Enters into an Exclusive License and Collaboration Agreement with Connect Biopharma Hongkong Limited in Relation to Rademikibart	Nov. 21	CI
Connect Biopharma Releases 'Positive' Stage 2 Atopic Dermatitis Trial Results; Unveils Licensing Deal; Shares Surge Premarket	Nov. 21	MT
Connect Biopharma Announces Positive Long-Term Data from the China Pivotal Trial of Rademikibart in Patients with Moderate-To-Severe Atopic Dermatitis	Nov. 21	CI
Connect Biopharma Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-12	CI
Connect Biopharma Holdings Limited Presents Additional Data from its Atopic Dermatitis Pivotal Trial in China at the 2023 World Congress of Dermatology	23-07-10	CI
Connect Biopharma Holdings Limited Announces Positive Long-Term Data from the Maintenance Period Through Week 48 of CN002 Phase 2 Icanbelimod Trial in Patients with Moderate-to-Severe Ulcerative Colitis	23-06-01	CI
Connect Biopharma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-11	CI
Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business Update	23-04-11	GL
Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business Update	23-04-11	GL
Connect Biopharma Holdings Limited Announces CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions	23-03-17	CI
Connect Biopharma Provides Business and Clinical Development Program Update	22-12-30	CI
Connect Biopharma Receives Nasdaq Non-Compliance Notice	22-12-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Connect Biopharma Holdings Limited

Equities

CNTB

US2075231017

Highlights

Filters